検索結果

2025 年 11 月 27 日 各 位 千寿製薬株式会社 アステラス製薬との「アイザベイ TM 硝子体内注射液 20mg/mL」に関する 販売パートナーシップ契約締結のお知らせ 千寿製薬株式会社（本社：大阪府大阪市、代表取締役社長：吉田周平、以下「千寿製薬」 ）は、 アステラス製薬株式会社（本社：東京、代表取締役社長CEO：岡村 直樹、以下「アステラス製 薬」 ）と、日本での「アイザベイTM（一

Research and Development System | Research & Development | SENJU Pharmaceutica

All things in nature have a reason for being. Today’s common sense is not common sense tomorrow. This is our motto. Senju Pharmaceutical has unique research systems, such as international joint resear

Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

Code of Conduct for Compliance The directors, employees and other members of Senju Pharmaceutical Co., Ltd. (“SENJU”) will act in compliance not only with the law but will operate under a high standar

Management Policy | About Senju | SENJU Pharmaceutical

“Being a good company” is our management policy. As a company that aims to be reliable, necessary and valuable for society, we are committed to pursuing happiness for all people associated with Senju

Management Policy | About Senju | SENJU Pharmaceutical

“Being a good company” is our management policy. As a company that aims to be reliable, necessary and valuable for society, we are committed to pursuing happiness for all people associated with Senju